TelyRx Reports Q3 Revenue of $23.1M, Up 88% Year Over Year
Revenue rose from $12.3 million a year earlier. Gross margin increased to 60% from 56%, while operating loss widened to $2.7 million from $0.9 million.
TelyRx Holdings Inc. reported Q3 2026 revenue of $23.1M, up 88% from $12.3M a year earlier. Gross margin rose to 60% from 56%, while operating loss widened to $2.7M from $0.9M.Material DetailsContext by AI AnalystThis is an early-stage growth profile, with revenue expanding rapidly while operating…